346 related articles for article (PubMed ID: 11869642)
1. Electrical cardioversion for atrial fibrillation and flutter.
Mead GE; Flapan AD; Elder AT
Cochrane Database Syst Rev; 2002; (1):CD002903. PubMed ID: 11869642
[TBL] [Abstract][Full Text] [Related]
2. Electrical cardioversion for atrial fibrillation and flutter.
Mead GE; Elder AT; Flapan AD; Kelman A
Cochrane Database Syst Rev; 2005 Jul; (3):CD002903. PubMed ID: 16034878
[TBL] [Abstract][Full Text] [Related]
3. WITHDRAWN: Electrical cardioversion for atrial fibrillation and flutter.
Mead GE; Elder A; Flapan AD; Cordina J
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD002903. PubMed ID: 29140555
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological cardioversion for atrial fibrillation and flutter.
Cordina J; Mead G
Cochrane Database Syst Rev; 2005 Apr; (2):CD003713. PubMed ID: 15846675
[TBL] [Abstract][Full Text] [Related]
5. External electrical and pharmacological cardioversion for atrial fibrillation, atrial flutter or atrial tachycardias: a network meta-analysis.
Kukendrarajah K; Ahmad M; Carrington M; Ioannou A; Taylor J; Razvi Y; Papageorgiou N; Mead GE; Nevis IF; D'Ascenzo F; Wilton SB; Lambiase PD; Morillo CA; Kwong JS; Providencia R
Cochrane Database Syst Rev; 2024 Jun; 6(6):CD013255. PubMed ID: 38828867
[TBL] [Abstract][Full Text] [Related]
6. WITHDRAWN: Pharmacological cardioversion for atrial fibrillation and flutter.
Cordina J; Mead GE
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD003713. PubMed ID: 29140557
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of pad placement for electrical cardioversion of atrial fibrillation/flutter: a systematic review.
Kirkland S; Stiell I; AlShawabkeh T; Campbell S; Dickinson G; Rowe BH
Acad Emerg Med; 2014 Jul; 21(7):717-26. PubMed ID: 25117151
[TBL] [Abstract][Full Text] [Related]
8. Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome.
Boriani G; Diemberger I; Biffi M; Domenichini G; Martignani C; Valzania C; Branzi A
Int J Clin Pract; 2007 May; 61(5):748-56. PubMed ID: 17493088
[TBL] [Abstract][Full Text] [Related]
9. Transoesophageal echocardiography-guided cardioversion of atrial fibrillation or flutter. Selection of a low-risk group for immediate cardioversion.
Roijer A; Eskilsson J; Olsson B
Eur Heart J; 2000 May; 21(10):837-47. PubMed ID: 10781356
[TBL] [Abstract][Full Text] [Related]
10. [Predictive factors of maintenance of sinus rhythm after direct current (DC) cardioversion of atrial fibrillation/atrial flutter].
Larsen MT; Lyngborg K; Pedersen F; Corell P
Ugeskr Laeger; 2005 Sep; 167(36):3408-12. PubMed ID: 16159494
[TBL] [Abstract][Full Text] [Related]
11. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
Lafuente-Lafuente C; Valembois L; Bergmann JF; Belmin J
Cochrane Database Syst Rev; 2015 Mar; (3):CD005049. PubMed ID: 25820938
[TBL] [Abstract][Full Text] [Related]
12. Thirty-day outcomes of emergency department patients undergoing electrical cardioversion for atrial fibrillation or flutter.
Xavier Scheuermeyer F; Grafstein E; Stenstrom R; Innes G; Poureslami I; Sighary M
Acad Emerg Med; 2010 Apr; 17(4):408-15. PubMed ID: 20370780
[TBL] [Abstract][Full Text] [Related]
13. [Drug and electrical therapy of supraventricular tachyarrhythmias].
Heisel A; Jung J; Schieffer H
Z Kardiol; 2000; 89 Suppl 3():68-74. PubMed ID: 10810788
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic versus direct-current electrical cardioversion of atrial flutter and fibrillation.
Van Gelder IC; Tuinenburg AE; Schoonderwoerd BS; Tieleman RG; Crijns HJ
Am J Cardiol; 1999 Nov; 84(9A):147R-151R. PubMed ID: 10568674
[TBL] [Abstract][Full Text] [Related]
15. Limitations of transesophageal echocardiography in the risk assessment of patients before nonanticoagulated cardioversion from atrial fibrillation and flutter: an analysis of pooled trials.
Moreyra E; Finkelhor RS; Cebul RD
Am Heart J; 1995 Jan; 129(1):71-5. PubMed ID: 7817928
[TBL] [Abstract][Full Text] [Related]
16. Thromboembolic events following cardioversion of acute atrial fibrillation and flutter: a systematic review and meta-analysis.
Wong BM; Perry JJ; Cheng W; Zheng B; Guo K; Taljaard M; Skanes AC; Stiell IG
CJEM; 2021 Jul; 23(4):500-511. PubMed ID: 33715143
[TBL] [Abstract][Full Text] [Related]
17. Factors predicting maintenance of sinus rhythm after direct current cardioversion of atrial fibrillation and flutter: a reanalysis with recently acquired data.
Arnar DO; Danielsen R
Cardiology; 1996; 87(3):181-8. PubMed ID: 8725311
[TBL] [Abstract][Full Text] [Related]
18. Determinants of successful direct current cardioversion for atrial fibrillation and flutter: the importance of rapid referral.
Houghton AR; Sharman A; Pohl JE
Br J Gen Pract; 2000 Sep; 50(458):710-1. PubMed ID: 11050786
[TBL] [Abstract][Full Text] [Related]
19. Cardioversion of persistent atrial flutter in non-anticoagulated patients at low risk for thromboembolism.
Bertaglia E; D'Este D; Franceschi M; Pascotto P
Ital Heart J; 2000 May; 1(5):349-53. PubMed ID: 10832811
[TBL] [Abstract][Full Text] [Related]
20. A new therapeutic strategy for electrical cardioversion of atrial fibrillation.
de Luca I; Sorino M; Del Salvatore B; de Luca L
Ital Heart J; 2001 Nov; 2(11):831-40. PubMed ID: 11770868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
